24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Uveitis
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:00
Lightricks challenges AI giants with open-source text-to-video platform
19:28
Full list of Israeli high-tech funding rounds in 2024
19:24
TailorMed raises $40 million in equity and debt to help patients access critical medications
18:17
Why Israeli tech companies are moving to Miami
More stories
Buzz
Most popular
Daily
Weekly
1
Stars over Athens: The who’s who at Calcalist's first Israel-Greece conference
2
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
3
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
More news
Uveitis
1 stories about Uveitis
How one female CEO overcame adversity to find a cure for Uveitis
04.02.22
|
Roni Dori
"I see us building a large company that will focus on the eye, beyond Uveitis. Our technology has tremendous potential to treat other diseases that cause blindness, and treat millions of patients," says Dr. Daphne Haim-Langford, who suffers from Uveitis and founded Tarsier Pharma
Please ensure Javascript is enabled for purposes of
website accessibility
